ADOC — Adocia SA Share Price
Last Trade - 00:00- €62.91m
- €62.99m
- FR₣0.84m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | FR₣m | 22.49 | 19.47 | 47.39 | 2.14 | 0.84 | 15.8 | 50.4 | -53.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin formulations for the treatment of diabetes: two formulations of insulin analog lispro (BioChaperone Lispro U100 and U200), a combination of basal insulin glargine and insulin lispro (BioChaperone Combo), and a combination of prandial insulin with amylin analog pramlintide: M1Pram. Its preclinical pipeline includes three products BioChaperone LisPram, BioChaperone Glargine GLP-1 and BioChaperone Glucagon GLP1.
Directors
- Gerard Soula (74)
- Olivier Soula DCE (48)
- Valerie Danaguezian
- You-Ping Chan
- Remi Soula
- Geraldine Soula
- Bertrand Alluis
- Richard Charvet
- Jose Correia
- David Duracher
- Martin Gaudier
- Stanislav Glezer (49)
- Sarah Gould
- Gregory Meiffren
- Laurent Arthaud (58)
- Olivier Martinez
- Stephane Boissel
- Kathy Bowdish
- Claudia Mitchell
- Ekaterina Smirnyagina (53)
- Dominique Takizawa (64)
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- January 1st, 2006
- Public Since
- February 20th, 2012
- No. of Employees
- 126
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 6,990,096
- Address
- 115 avenue Lacassagne, LYON, 69003
- Web
- https://www.adocia.com/
- Phone
- +33 472610610
- Contact
- Valerie Danaguezian
- Auditors
- Ernst & Young et Autres
Latest News for ADOC
Upcoming events for ADOC
Similar to ADOC
ABIONYX PHARMA ORD
Euronext - Paris
BIOPHYTIS ORD
Euronext - Paris
ERYTECH PHARMA ORD
Euronext - Paris
GENSIGHT BIOLOGICS ORD
Euronext - Paris
INVENTIVA ORD
Euronext - Paris
FAQ
As of Today at 19:55 UTC, shares in Adocia SA are trading at €9.00. This share price information is delayed by 15 minutes.
Shares in Adocia SA last closed at €9.00 and the price had moved by +9.76% over the past 365 days. In terms of relative price strength the Adocia SA share price has underperformed the FTSE Global All Cap Index by -14.78% over the past year.
The overall consensus recommendation for Adocia SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Adocia SA does not currently pay a dividend.
Adocia SA does not currently pay a dividend.
Adocia SA does not currently pay a dividend.
To buy shares in Adocia SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €9.00, shares in Adocia SA had a market capitalisation of €62.91m.
Here are the trading details for Adocia SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ADOC
Based on an overall assessment of its quality, value and momentum Adocia SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Adocia SA is €17.33. That is 92.56% above the last closing price of €9.00.
Analysts covering Adocia SA currently have a consensus Earnings Per Share (EPS) forecast of -FR₣2.33 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adocia SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -27.17%.
As of the last closing price of €9.00, shares in Adocia SA were trading -3.03% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Adocia SA.
Adocia SA's management team is headed by:
- Gerard Soula -
- Olivier Soula - DCE
- Valerie Danaguezian -
- You-Ping Chan -
- Remi Soula -
- Geraldine Soula -
- Bertrand Alluis -
- Richard Charvet -
- Jose Correia -
- David Duracher -
- Martin Gaudier -
- Stanislav Glezer -
- Sarah Gould -
- Gregory Meiffren -
- Laurent Arthaud -
- Olivier Martinez -
- Stephane Boissel -
- Kathy Bowdish -
- Claudia Mitchell -
- Ekaterina Smirnyagina -
- Dominique Takizawa -
We do not have data on Adocia SA's shareholders